№ lp_1_2_53342
File format: docx
Character count: 3664
File size: 36 KB
Year:
2020
Region / City:
Long Beach, CA
Topic:
Academic Senate Meeting Minutes
Document Type:
Meeting Minutes
Organization:
California State University, Long Beach
Author:
Academic Senate
Target Audience:
University faculty, staff, and students
Period of Validity:
September 10, 2020
Approval Date:
September 10, 2020
Date of Changes:
None
Contextual description:
Meeting minutes detailing the discussions and decisions made during the Academic Senate meeting at California State University, Long Beach, on September 10, 2020.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2025
Region / City:
Australia
Topic:
Pharmaceutical submission for drug listing
Document Type:
Pharmaceutical submission
Organization:
Janssen-Cilag Pty Ltd
Author:
Not specified
Target Audience:
Healthcare professionals, regulatory authorities
Validity Period:
Not specified
Approval Date:
Not specified
Date of Changes:
March 2025
Note:
Context
Note:
Year
Location:
Academic Senate Conference Room (AS 125)
Year:
2019
Region / City:
Long Beach, California
Subject:
Executive Committee Meeting Minutes
Document Type:
Meeting Minutes
Organization / Institution:
California State University, Long Beach (CSULB)
Author:
J. Pandya, N. Hultgren, M. Aliasgari, N. Meyer-Adams, C. Cummings, P. Hung, D. Stewart, N. Schürer, K. Janousek, E. Klink, P. Soni, J. Phillips, D. Hamm, K. Bonetati, J. Hamilton, S. Apel, B. Jersky, J. Cormack, A. Kinsey
Target Audience:
Faculty, Academic Senate, Executive Committee members
Period of Validity:
Not specified
Approval Date:
August 27, 2019
Amendment Date:
Not specified
Type of document:
Pharmaceutical Benefits Advisory Committee (PBAC) submission and assessment report
Medicine:
Aripiprazole long-acting injectable (AOM)
Dosage forms/strengths:
Powder for injection 300 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe; Powder for injection 400 mg (as monohydrate) with diluent in pre-filled dual-chamber syringe
Brand:
Abilify Maintena
Sponsor:
Lundbeck Australia Pty Ltd
Purpose of submission:
Request for General Schedule Authority Required (STREAMLINED) PBS listing of AOM pre-filled syringe dose form
Indication:
Treatment of schizophrenia
Comparator:
AOM modified release injection vial kit (therapeutic vial kits)
Regulatory status:
TGA registered 7 May 2018 for acute and maintenance treatment of schizophrenia in adults and maintenance treatment of bipolar I disorder (monotherapy)
Previous PBAC consideration:
400 mg AOM PFS recommended July 2018; recommendation rescinded March 2023
Pricing basis:
Cost-minimisation versus AOM vial kit with equivalent pricing (no price premium)
Price levels referenced:
DPMQ, PTP, AEMP (current as of 1 June 2025)
Estimated PBS usage:
400,000 to <500,000 scripts over first six years (Year 1 10,000–<20,000; Year 6 100,457)
Indication listing conditions:
Authority Required (Streamlined); prescriber types include medical practitioners and nurse practitioners; general schedule (Code GE)
Year:
2025
Region / City:
South Africa
Theme:
Procurement, Education, Technology
Document Type:
Request for Quotation (RFQ)
Organization:
SITA (State Information Technology Agency)
Author:
N/A
Target Audience:
Bidders for RFQ
Validity Period:
200 Days from Closing Date
Approval Date:
N/A
Amendment Date:
N/A
Year:
2025
Region / city:
United Kingdom
Subject:
Market-wide Half Hourly Settlement (MHHS) Programme Changes
Document type:
Release notes
Author:
Not specified
Target audience:
Industry stakeholders
Period of validity:
From 22/09/2025 onwards
Approval date:
22/09/2025
Date of changes:
Not specified
Context:
These release notes outline proposed changes related to the implementation of Market-wide Half Hourly Settlement (MHHS) in the UK energy market, detailing modifications to central switching services, data formats, and incentive schemes.
Year:
2025
Region / City:
Maryland
Theme:
College Completion, Education Grants
Document Type:
Grant Program Proposal
Organization:
Maryland Higher Education Commission (MHEC)
Author:
Maryland Higher Education Commission
Target Audience:
Higher Education Institutions, Grant Applicants
Period of Effect:
2025-2026
Approval Date:
June 25, 2025
Amendment Date:
N/A
Academic year:
2024–2025
Sport:
Boys’ Tennis
Award name:
All-Academic 4.00 Scholar Team
Eligibility:
Senior student-athletes
Selection criteria:
Highest grade point averages across all classes and divisions
Grade point average:
4.0000
Recognition:
Honored during state championships and by participating schools
Document type:
Academic honors roster
Participant information:
Name, year, school, class, division, GPA
Year:
2021
Region / City:
Maine
Topic:
Solid Waste Management
Document Type:
Regulation
Authority:
Department of Environmental Protection
Audience:
Public and Solid Waste Facility Operators
Period of Effect:
Ongoing
Date of Approval:
February 9, 2021
Date of Amendments:
None
Year:
2023
Region / City:
Australia
Topic:
Medical treatment, Oncology, Myeloma
Document Type:
Medical Submission
Organization / Institution:
Janssen-Cilag Pty Ltd
Author:
Unknown
Target Audience:
Healthcare professionals, regulatory bodies
Period of validity:
Ongoing, until treatment approval
Approval Date:
April 2020 (IV formulation), September 2020 (SC formulation)
Date of amendments:
Various PBAC meeting dates (2017-2022)
Year:
2015
Region / City:
New Delhi
Subject:
Transmission Service Provider Selection
Document Type:
Request for Qualification (RFQ)
Organization:
PFC Consulting Limited
Author:
PFC Consulting Limited
Target Audience:
Bidders for Transmission Service Provider
Period of Validity:
N/A
Approval Date:
October 15, 2015
Amendment Date:
N/A
Year:
2026
Region / City:
Australia
Topic:
Nutritional Formulation, Food for Special Medical Purposes
Document Type:
Submission to PBAC
Organization / Institution:
PBAC, Nutricia Australia Pty Ltd
Author:
Nutricia Australia Pty Ltd
Target Audience:
Healthcare professionals, regulatory bodies, pediatricians
Validity Period:
Ongoing
Approval Date:
1 August 2002
Date of Change:
2011, 2026
Requested Change:
Formulation modification to comply with EU regulations
Status:
Approved for continued listing
Year:
2018
Region / City:
N/A
Topic:
Firefighting equipment / vehicle specification
Document Type:
Technical Specification
Institution:
Ford
Author:
N/A
Target Audience:
Firefighting departments, emergency response teams
Period of Action:
N/A
Approval Date:
N/A
Date of Changes:
N/A
Year:
2025
Region / City:
Loleta, CA
Topic:
Tribal Council Meeting
Document Type:
Agenda
Organization / Institution:
Wiyot Tribal Council
Author:
Wiyot Tribal Council
Target Audience:
Tribal Council Members, Staff, and Guests
Action Period:
March 10, 2025
Approval Date:
March 10, 2025
Modification Date:
N/A
KHG Housing Strategy and Enabling Subgroup Meeting Notes, 13th January 2026, 2:00 – 3:30pm, on Teams
Year:
2026
Region / City:
Kent & Medway
Topic:
Housing Strategy and Affordable Housing
Document Type:
Meeting Notes
Organization:
Kent Housing Group (KHG)
Author:
N/A
Target Audience:
KHG members, local authorities, housing professionals
Period of Effectiveness:
N/A
Approval Date:
13th January 2026
Date of Changes:
N/A
Year:
2024
Region / City:
Australia
Topic:
Medicinal Product Registration
Document Type:
Submission Report
Agency:
Therapeutic Goods Administration (TGA)
Author:
GlaxoSmithKline Australia
Target Audience:
Medical Practitioners
Treatment Phase:
Initial Treatment
Indication:
Myelofibrosis, including primary, post-polycythaemia vera, and post-essential thrombocythaemia myelofibrosis
Approval Status:
Pending
Date of Submission:
May 2024
Date of Approval:
Not yet approved
Background:
Momelotinib is currently approved in the UK, US, Japan, and the EU.
Description:
Clinical submission for listing momelotinib under the Australian PBS for the treatment of myelofibrosis in patients with moderate to severe anaemia.
Year:
2019
Region / City:
San Clemente, CA
Subject:
Criminal Law
Document Type:
Course Outline
Institution:
Grossmont College
Author:
Richard Michelson, James Zuffoletto, M. R. Lippman
Target Audience:
Students of Criminal Justice
Period of Application:
Fall Semester 2019
Approval Date:
December 13, 2019
Location:
Academic Senate Conference Room (AS 125)
Year:
2019
Region / City:
Long Beach, California
Subject:
Executive Committee Meeting Minutes
Document Type:
Meeting Minutes
Organization / Institution:
California State University, Long Beach (CSULB)
Author:
J. Pandya, N. Hultgren, M. Aliasgari, N. Meyer-Adams, C. Cummings, P. Hung, D. Stewart, N. Schürer, K. Janousek, E. Klink, P. Soni, J. Phillips, D. Hamm, K. Bonetati, J. Hamilton, S. Apel, B. Jersky, J. Cormack, A. Kinsey
Target Audience:
Faculty, Academic Senate, Executive Committee members
Period of Validity:
Not specified
Approval Date:
August 27, 2019
Amendment Date:
Not specified
Note:
Year